Citigroup Upgrades Nevro to Neutral, Announces $6.89 Price Target
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has upgraded Nevro (NYSE:NVRO) from Sell to Neutral and set a price target of $6.89.

August 09, 2024 | 11:17 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Joanne Wuensch has upgraded Nevro from Sell to Neutral and set a price target of $6.89.
The upgrade from Sell to Neutral by a major financial institution like Citigroup is likely to have a positive short-term impact on Nevro's stock price. The new price target of $6.89 provides a specific valuation that investors can consider.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100